BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 7
• 8
• 9

• Press Releases

  Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress

  June 8, 2026

   · 

  3 min read
• Press Releases

  Engitix Announces Strategic Collaboration with GSK to Advance First-in-Class Targets for Liver Fibrosis Regression

  June 8, 2026

   · 

  2 min read
• Press Releases

  Tango Therapeutics Announces Combination of Vopimetostat and Daraxonrasib Demonstrated 92% Objective Response Rate in Pancreatic Cancer

  June 8, 2026

   · 

  11 min read
• Press Releases

  Anteris Advances Global PARADIGM Expansion with French Regulatory Clearance

  June 8, 2026

   · 

  4 min read
• Press Releases

  Kymera Therapeutics Presents New Preclinical Lupus Data for KT-579, First-in-Class, Oral IRF5 Degrader, at EULAR and FOCIS Congresses

  June 8, 2026

   · 

  8 min read
• Press Releases

  Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

  June 8, 2026

   · 

  5 min read
• Press Releases

  Ceribell Announces New Critical Care Medicine Publication Reinforcing Link Between Seizure Burden Measured by Clarity AI Algorithm and Neurological Outcomes

  June 8, 2026

   · 

  5 min read
• Press Releases

  Marvel Biosciences Receives Notice of Allowance for Australian Patent Application Covering Composition of Matter for its Lead Therapeutic Candidate MB-204

  June 8, 2026

   · 

  5 min read
• Press Releases

  Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives

  June 8, 2026

   · 

  13 min read
• Press Releases

  Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

  June 8, 2026

   · 

  12 min read